Treace Medical Concepts announced the successful completion of the first cases combining IntelliGuide PSI (patient-specific instrumentation) technology with the Adductoplasty system for a CT-based, patient-specific correction personalized to the patient’s unique midfoot deformity.

IntelliGuide PSI, which incorporates RedPoint technology, is the first, only patient-specific cut guide system today for correction of bunion and/or midfoot deformities in the U.S. IntelliGuide PSI leverages artificial intelligence (AI)-enabled software to convert a patient’s CT scan to a pre-op surgical plan and generate a 3D-printed cut guide specific to the patient’s deformity.

The company acquired RedPoint in a deal valued at up to $30 million in June 2023.

Treace began limited market release of IntelliGuide PSI for the Adductoplasty procedure and expects to expand IntelliGuide’s surgeon access for both the Lapiplasty and Adductoplasty procedures over the coming months. Full market release is anticipated in H1 2025.

“IntelliGuide PSI further advances our market leadership position in the surgical management of bunion and midfoot deformities, extending the established benefits of PSI personalized approaches to our Lapiplasty and Adductoplasty Procedures,” said John T. Treace, CEO, founder and board member of Treace. “We look forward to further building out our ecosystem of enabling digital technologies as part of our strategy to provide a comprehensive portfolio of bunion and related midfoot solutions to address the evolving needs of our surgeon customers and patients.”

Eric Kuhlman, DPM of Center for Spine & Orthopedics in Denver performed an initial IntelliGuide Adductoplasty case. Dr. Kuhlman said the technology will revolutionize how he approaches treating patients with bunion and related midfoot deformities.

“The virtual planning process helped me fully visualize the complex three-dimensional metatarsus adductus midfoot correction before stepping foot in the OR and the 3D-printed cut guides added a new level of intra-operative precision, efficiency, and confidence to the procedure,” Dr. Kuhlman told the press. “Just as PSI has advanced other areas of orthopedics, I expect IntelliGuide PSI to rapidly expand our understanding and treatment of these common, yet challenging foot deformities.”